Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Unlocking New Opportunities in Asia and the Greater Bay Area 2025-07-17 09:55
Nature Medicine Published Phase 1 Results of Innovent Biologics' Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma 2025-07-17 08:00
Health In Tech Supports Foster Closet to Help Children and Families in Need 2025-07-17 04:30
Flat Medical Honored at Premier, Inc.'s Annual Supplier Innovation Celebration 2025-07-16 21:30
SNB-101 Earns Government Backing as Promising Therapy for Small Cell Lung Cancer 2025-07-16 20:00
The 2025 Mammoth International Contest on Omics Sciences - Young Scientists Track Now Open for Hot Registration! 2025-07-16 18:12
WuXi Biologics Granted Highest Negligible-Risk ESG Rating from Morningstar Sustainalytics 2025-07-16 18:00
JETRO and METI Hold First-ever "Global Healthcare Challenge," Featuring International Symposium in Healthcare Sector and Pitch Competition among World's Startups 2025-07-16 14:00
Senhwa Biosciences announces first patient dosed in NCI-sponsored pilot study of Pidnarulex (CX-5461) pharmacodynamics in patients with advanced solid tumors 2025-07-16 10:32
Akeso Announces First Patient Enrolled in the Phase III Trial（AK112-312/HARMONi-GI6）of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer 2025-07-16 09:47
Avio Health Launches AI Platform to Turn Disconnected Health Data into Preventive Intelligence 2025-07-15 21:41
Introducing the VARON VP-8G: A Smarter, Lighter Portable Oxygen Concentrator Built for Life on the Move 2025-07-15 20:25
OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company 2025-07-15 19:30
Youthful Narrative Bridges Traditional Chinese Medicine to Global Audience 2025-07-15 16:45
Baraya Extended Care Closes Series B Funding Round Bringing Total Capital Raised to USD 124 Million from TVM Capital Healthcare and a Syndicate of Prominent Investors 2025-07-15 14:00
Ascletis Completes Dosing of All Participants in Its U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity 2025-07-15 07:00
Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma 2025-07-15 04:05
Health In Tech to Announce Second Quarter 2025 Financial Results on July 21, 2025 2025-07-15 01:00
Zepp Health Corporation to Report Second Quarter 2025 Financial Results on August 3, 2025 2025-07-14 19:00
Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform 2025-07-14 15:38
1 27 28 29 30 31 872